Market Closed -
Other stock markets
|
After market 12:36:04 am | |||
71.58 EUR | +0.66% | 71.74 | +0.22% |
06:47pm | BNP to buy Neuflize Vie from Axa, ABN Amro, Les Echos reports | RE |
05:46pm | Novo Nordisk Taps Banks for Potential Bond Issue | MT |
Sales 2024 * | 4.8TCr 5.18TCr 4,32300Cr | Sales 2025 * | 5.03TCr 5.43TCr 4,52800Cr | Capitalization | 8.04TCr 8.68TCr 7,24500Cr |
---|---|---|---|---|---|
Net income 2024 * | 1.06TCr 1.14TCr 95TCr | Net income 2025 * | 1.14TCr 1.23TCr 1,02500Cr | EV / Sales 2024 * | 1.68 x |
Net cash position 2024 * | - 0 0 | Net cash position 2025 * | - 0 0 | EV / Sales 2025 * | 1.6 x |
P/E ratio 2024 * |
7.8
x | P/E ratio 2025 * |
7.1
x | Employees | 1,83,000 |
Yield 2024 * |
6.52% | Yield 2025 * |
7.08% | Free-Float | 86.88% |
Latest transcript on BNP Paribas
1 day | +0.89% | ||
1 week | +4.80% | ||
Current month | +6.23% | ||
1 month | +8.93% | ||
3 months | +33.15% | ||
6 months | +28.12% | ||
Current year | +13.94% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 62 | 01/93/01 | |
Lars Machenil
DFI | Director of Finance/CFO | 54 | 01/12/01 |
Bernard Gavgani
CTO | Chief Tech/Sci/R&D Officer | 65 | 01/95/01 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 64 | 11/11/11 | |
Director/Board Member | 71 | 04/09/04 | |
Director/Board Member | 64 | 10/01 |
Date | Price | Change | Volume |
---|---|---|---|
13/24/13 | 71.58 | +0.66% | 5 549 |
10/24/10 | 71.11 | +0.61% | 4,141 |
09/24/09 | 70.68 | +1.12% | 3,629 |
08/24/08 | 69.9 | +0.34% | 3,971 |
07/24/07 | 69.66 | +1.99% | 4,813 |
Delayed Quote Xetra, May 13, 2024 at 09:05 pm IST
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+16.96% | 57TCr | |
+14.12% | 30TCr | |
+18.85% | 25TCr | |
+25.03% | 22TCr | |
+21.08% | 18TCr | |
+25.17% | 17TCr | |
+10.02% | 16TCr | |
+6.62% | 15TCr | |
-14.86% | 13TCr |
- Stock Market
- Equities
- BNP Stock
- BNP Stock